The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

AUTOR(ES)

Eichhorn, Eric J

FONTE

BioMed Central

RESUMO

Previous trials (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure [MERIT-HF], Cardiac Insufficiency Bisoprolol Study [CIBIS] II) have demonstrated a mortality benefit of β-adrenergic blockade in patients with mild to moderate heart failure. The recent Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial has extended these results to a more advanced patient population. This trial did not, however, include patients who could not reach compensation, patients with far advanced heart failure symptoms, or a significant number of black patients. Future studies of β-blockade may focus on these patients or patients with asymptomatic left ventricular dysfunction.

Documentos Relacionados

• A prospective randomized trial comparing open versus laparoscopic appendectomy.
• A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy.
• Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial.
• Hyoscine butylbromide for colorectal polyp detection: prospective, randomized, placebo-controlled trial
• Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.